MLB

Coming off suspension, Byrd signs minor league deal with Mets

{eot}
Associated Press
2/1/2013 7:26:01 PM
Decrease Text SizeIncrease Text Size
Text Size

NEW YORK -- The New York Mets have agreed to a minor league contract with outfielder Marlon Byrd, who served a 50-game suspension last season after testing positive in June for a performance enhancing drug while he was a free agent.

An NL All-Star in 2010, Byrd was traded from the Chicago Cubs to Boston Red Sox on April 21. Boston released him on June 12. Two weeks later, MLB announced he tested positive for Tamoxifen, which can reduce side effects of steroid use and increase testosterone.

Byrd hit .210 in 47 games for Boston and Chicago last season, and has hit .278 in 11 big league seasons with 82 homers and 445 RBIs.

The 35-year-old gives the Mets another potential option in the outfield, an area in which they are considered to be very weak. This off-season they cut ties with Jason Bay and lost centre fielder Andres Torres, who signed with San Francisco, and Scott Hairston, who appears headed to the Cubs.

Marlon Byrd (Photo: The Canadian Press)

zoom

(Photo: The Canadian Press)
Share This

Share This

Add to FacebookAdd to DiggAdd to FarkAdd to TwitterAdd to Stumble UponAdd to Reddit
Print this Story



Baseball Canada

Keep up with the latest on Canada's national programs from the governing body for amateur baseball in Canada.


Baseball Canada Website

Podcasts

TSN 1050: The Baseball Podcast : Episode 17 - Aug. 6th

Scott MacArthur, Richard Griffin & Gregor Chisholm discuss quiet trade deadline for the Blue Jays, struggling rotation & potential Biogenesis fallout.

TSN 1050: The Baseball Podcast: July 30 - Episode 15

Scott MacArthur & Toronto Star's Richard Griffin preview the trade deadline, Blue Jays' needs & being on Boston as Jon Lester rumours ramp up.

TSN 1050: Blue Lunch: July 9 - John McDonald

LA Angels infielder, John McDonald joined Blue Lunch to discuss his career from the time he left Toronto to the present.


More Podcasts

© 2014
All rights reserved.
Bell Media Television